Casagrande, N., Borghese, C. and Aldinucci, D. (2021) “In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability”, Haematologica. Pavia, Italy, 107(1), pp. 287-291. doi: 10.3324/haematol.2021.279389.